Metagenomi, Inc. Common Stock (MGX)
Healthcare
Biotechnology
1.20 $
+1.7%
vs. previous close
Closing price · As of: 3. Aug 2026
Metagenomi, Inc. Common Stock (MGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -21 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -26 | -24 | -21 | -30 | -26 | -27 | -26 | -23 | -21 | -21 | -24 | -21 | -87 | |
| 1.0 | 1.2 | 1.2 | 1.3 | 1.3 | 1.4 | 1.5 | 1.4 | 1.3 | 1.3 | 1.3 | 1.3 | 5.2 | |
| 0.7 | 3.3 | 2.5 | 5.1 | 4.5 | 3.2 | 3.4 | 2.9 | 3.2 | 3.0 | 2.7 | 2.6 | 11 | |
| -10 | -6.9 | -4.4 | -11 | -21 | -13 | -15 | -2.3 | -7.9 | -5.6 | -6.2 | -2.9 | -23 | |
| 3.2 | 2.3 | 1.7 | 0.9 | 0.7 | 1.2 | 0.3 | 0.3 | 0.1 | 0.1 | 0.1 | 0.0 | 0.3 | |
| -19 | 76 | 61 | -95 | -13 | -8.9 | 29 | 25 | 19 | 27 | 32 | 4.0 | 83 | |
| – | – | – | – | -2.0 | – | – | – | – | – | – | – | – | |
| 0.0 | -1.9 | -1.3 | 87 | -2.0 | -0.5 | 0.0 | -0.1 | -0.2 | -0.2 | 0.1 | 0.0 | -0.3 | |
| -45 | 50 | 39 | -38 | -41 | -36 | 2.3 | 1.8 | -2.3 | 5.9 | 8.9 | -16 | -3.9 | |
| -29 | -26 | -22 | -31 | -27 | -28 | -27 | -23 | -21 | -21 | -24 | -21 | -88 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.